Skip to main content
2023 Midyear Clinical Meeting & Exhibition Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certfified Pharmacy Executive Leader (CPEL)
Certfified Pharmacy Executive Leader (CPEL)
Integrated Informatics Institute
Integrated Informatics Institute
Back
Handout

Educational Sessions

Antithrombotics in Valvular Heart Disease: Not Necessarily an Exclusion

Tuesday, December 5, 2023
4:00 PM – 5:00 PM  
Location: ACC, Room 204b, Level 2
CE Credits 1.00 contact hours
Activity #: 0204-0000-23-301-L01-P
Activity Type: Application-based
Target Audience: Pharmacist

Learning Objectives:

  • Determine whether patients undergoing transcatheter valve replacement require single-antiplatelet, dual antiplatelet, or oral anticoagulant therapy.
  • Evaluate the risk of thrombosis versus bleeding for patients undergoing surgical bioprosthetic valve replacement.
  • Recommend an antithrombotic regimen that balances thrombosis and bleeding in a patient undergoing surgical bioprosthetic valve replacement.
  • Apply available evidence to determine appropriate anticoagulation regimens for those with valvular atrial fibrillation based on the severity of rheumatic heart disease.